Strategy, finance, and corporate development finally debate tomorrow’s plan against the same governed substrate commercial and medical run on. TAM resolved to the practice level. M&A targets ranked on Axiogen Tier and growth velocity. Board metrics auto-assembled with full provenance.
Strategy, M&A, finance, and the executive office share the same records, the same provenance, and the same governed event stream — with surfaces tuned to their work.
Stop arguing about denominator. Total addressable market broken down by region, modality, brand affinity, and Axiogen Tier — auditable to the underlying records.
Every independent practice and group ranked on velocity, Axiogen Tier, brand mix, and KOL footprint — with cluster-level synergy modeling and conflict screens.
Quarterly metrics — share by territory, conquest velocity, KOL coverage, channel mix — auto-assembled from the same governed substrate every other team runs on.
Commercial, medical, operations, and finance argue strategy against the same data — not against each other’s spreadsheets. Strategy moves at the speed of consensus, not reconciliation.
A 30-minute exec briefing, a live TAM walkthrough on your portfolio, and a concrete rollout plan for Strategy, Corporate Development, and Finance.